SCHEMBL17218868

SCHEMBL17218868

CCc1cccc(/[C]=N\OCc2ccc(C)cc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.37
▸ AGXT P21549 2/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MAOA P21397 1/20 0.34
▸ RAPGEF4 Q8WZA2 1/20 0.33
▸ MMP2 P08253 2/20 0.33
▸ MMP12 P39900 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17218871 1.00 MAOB (0.37) MAOBAGXTKCNH2MAOARAPGEF4
SCHEMBL17215895 0.93 TP53 (0.35) RAB9AGAAMAPTL3MBTL1NPC1
SCHEMBL17215896 0.93 TP53 (0.35) RAB9AGAAMAPTL3MBTL1NPC1
SCHEMBL17216570 0.90 TP53 (0.39) MAOBRAB9AGAAMAPTL3MBTL1
SCHEMBL17216567 0.90 TP53 (0.39) MAOBRAB9AGAAMAPTL3MBTL1
SCHEMBL17218343 0.89 IDO1 (0.45) MAOBMAOARAPGEF4MMP2MMP12
SCHEMBL17218346 0.89 IDO1 (0.45) MAOBMAOARAPGEF4MMP2MMP12
SCHEMBL17216369 0.88 KDM1A (0.33) AGXTMAPTSMN1; SMN2IDO1GRM5
SCHEMBL17216367 0.88 KDM1A (0.33) AGXTMAPTSMN1; SMN2IDO1GRM5
SCHEMBL17218364 0.87 PPARG (0.37) MAOBAGXTMAOARAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2940012-B1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-30 — — EP disclosed
US-9560850-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-07 — — US disclosed
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-11-26 — — US disclosed
EP-2940012-A1 TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF Sumitomo Chemical Company Limited (JP) 2015-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336908-A1 TETRAZOLINONE COMPOUND AND USE THEREOF RTN3, CYP51A1, TCOF1 MAOB 3611/4885AGXT 1423/4885KCNH2 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback